NCT00625365

A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

CARES (Contrast EchocArdiography REgistry for Safety Surveillance): A Prospective, Phase IV, Open-Label, Nonrandomized, Multicenter, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1,060 (actual)
• Sponsor: Lantheus Medical Imaging · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this registry study is to gather safety information on the current clinical use of and the safety of DEFINITY®

Conditions

• Cardiovascular Disease

Interventions

Type	Name	Description
DRUG	DEFINITY®	DEFINITY may be injected by either an intravenous or bolus injection or infusion. Dosage as per standard clinical practice and Package Insert

Timeline

• Start date: 2008-02-01
• Primary completion: 2009-05-01
• Completion: 2009-07-01
• First posted: 2008-02-28
• Last updated: 2020-11-24
• Results posted: 2011-01-14

Locations

16 sites across 1 country: United States